Detalhe da pesquisa
1.
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
Lancet
; 403(10422): 147-159, 2024 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38008109
2.
Remibrutinib demonstrates favorable safety profile and sustained efficacy in chronic spontaneous urticaria over 52 weeks.
J Allergy Clin Immunol
; 153(2): 479-486.e4, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37866460
3.
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials.
J Allergy Clin Immunol
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38431226
4.
Efficacy and safety of on-demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trial.
Allergy
; 79(1): 93-103, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37597162
5.
Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase 2b multinational, randomised, double-blind, placebo-controlled ARROYO trial.
Br J Dermatol
; 2024 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38367194
6.
Solar Urticaria: An Ambispective Study in a Long-term Follow-up Cohort with Emphasis on Therapeutic Predictors and Outcomes.
Acta Derm Venereol
; 104: adv25576, 2024 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38189220
7.
Differential diagnosis of contact dermatitis: A practical-approach review by the EADV Task Force on contact dermatitis.
J Eur Acad Dermatol Venereol
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38713001
8.
Polysensitization in the Spanish Contact Dermatitis Registry (REIDAC): A 2019-2022 prospective study with cluster and network analysis.
J Eur Acad Dermatol Venereol
; 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38411353
9.
Severely compromised supply of patch test allergens in Europe hampers adequate diagnosis of occupational and non-occupational contact allergy. A European Society of Contact Dermatitis (ESCD), European Academy of Allergy and Clinical Immunology (EAACI), European Academy of Dermatology and Venereology (EADV) task forces 'Contact Dermatitis' and 'Occupational Skin Disease' position paper.
Contact Dermatitis
; 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38812248
10.
2-Hydroxyethyl methacrylate (2-HEMA) sensitization, a global epidemic at its peak in Spain?
Contact Dermatitis
; 90(5): 507-513, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38351475
11.
Sensitization to textile dyes in Spain: Epidemiological situation (2019-2022).
Contact Dermatitis
; 90(5): 486-494, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38348533
12.
Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study.
J Allergy Clin Immunol
; 152(5): 1095-1106, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37574079
13.
[[Translated article]]Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC). / Actualización de la batería estándar y batería ampliada de pruebas alérgicas de contacto por el Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (GEIDAC).
Actas Dermosifiliogr
; 2024 May 30.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38823769
14.
Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances.
Allergy
; 78(2): 389-401, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36448493
15.
Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: Results of PREG-CU, a UCARE study.
J Eur Acad Dermatol Venereol
; 37(2): 356-364, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36066999
16.
Which outcomes should be measured in hand eczema trials? Results from patient interviews and an expert survey.
J Eur Acad Dermatol Venereol
; 37(6): 1199-1206, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36695080
17.
Allergic reactivity for different dilutions of eugenol in repeated open application test and patch testing.
Contact Dermatitis
; 89(2): 95-102, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37218587
18.
The European baseline series and recommended additions: 2023.
Contact Dermatitis
; 88(2): 87-92, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36443008
19.
Occupational contact allergy: The European perspective-Analysis of patch test data from ESSCA between 2011 and 2020.
Contact Dermatitis
; 88(4): 263-274, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36694979
20.
Sensitization to isothiazolinones in the Spanish Contact Dermatitis Registry (REIDAC): 2019-2021 epidemiological situation.
Contact Dermatitis
; 88(3): 212-219, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36403138